Unlock Exclusive Discounts & Flash Sales! Click Here to Join the Deals on Every Wednesday!
The global pandemic caused by SARS-CoV-2 remains a medical threat to humanity, as multiple variants continue to evolve and develop resistance to vaccines and previous infections. Monoclonal antibodies (mAbs), which can be used for treatment and prevention. Studies have shown that COVA309-35 has strong neutralization ability against autologous virus as well as Omicron BA.1 and Ba.1.